Aztreonam Dosing for Elderly Female with eGFR 87 mL/min
For this elderly female patient with eGFR 87 mL/min and an infected heel wound, administer aztreonam 1-2 g IV every 8 hours without dose reduction, as her renal function does not require adjustment.
Rationale for Standard Dosing
With an eGFR of 87 mL/min, this patient has normal to mildly reduced renal function and does not meet criteria for dose adjustment. The FDA label specifies that dose reduction is only required when creatinine clearance falls below 30 mL/min 1. The standard adult dosing table clearly indicates 1-2 g every 8 hours for moderately severe to severe systemic infections 1.
Specific Dosing Recommendations
For the infected heel wound (skin and soft tissue infection):
- Dose: 1-2 g IV every 8 hours
- Route: Intravenous (preferred for systemic infections)
- Duration: Continue for at least 48 hours after clinical improvement or evidence of bacterial eradication 1
The choice between 1 g and 2 g depends on infection severity. For a moderate wound infection, 1 g every 8 hours is appropriate. If there are signs of severe infection, deep tissue involvement, or systemic toxicity, use 2 g every 8 hours [@1,2@].
Age-Related Pharmacokinetic Considerations
While elderly patients show altered aztreonam pharmacokinetics—including increased half-life (3.1 vs 1.8 hours) and AUC compared to younger adults 2—these changes are primarily driven by renal function decline, not age per se 1. The FDA label explicitly states that "renal status is a major determinant of dosage in the elderly" and that "the dosage of AZACTAM should be adjusted accordingly" based on creatinine clearance 1.
Critical point: With eGFR 87 mL/min, this patient's renal clearance remains adequate (normal is >90 mL/min), so standard dosing applies despite her age 1.
When Dose Adjustment IS Required
Dose reduction becomes necessary only at lower renal function thresholds 1:
- eGFR 10-30 mL/min: Give loading dose (1-2 g), then reduce maintenance dose by 50% at usual intervals
- eGFR <10 mL/min (including hemodialysis): Give loading dose, then reduce to 25% of usual dose at standard intervals, plus 1/8 of initial dose after each dialysis session
Monitoring Parameters
- Renal function: Monitor serum creatinine during therapy, as aztreonam pharmacokinetics are highly dependent on renal clearance 1
- Clinical response: Assess wound healing, systemic signs of infection
- Duration: Typical course 7-14 days for skin/soft tissue infections, but may require longer for deep or persistent infections 1
Common Pitfalls to Avoid
- Do not reduce dose based on age alone—only adjust for measured renal impairment [@13,15@]
- Do not use serum creatinine alone in elderly patients, as it may appear normal despite reduced GFR due to decreased muscle mass 1
- Do not underdose—elderly patients with preserved renal function require full therapeutic doses to achieve adequate tissue penetration 2
The evidence consistently demonstrates that aztreonam is safe and effective in elderly patients when dosed appropriately for renal function 3, with no increased adverse events compared to younger patients when renal status is accounted for 4.